Western tradition · NAD Precursor

Nicotinamide Riboside (NR)

The leading NMN alternative — a direct NAD+ precursor with multiple RCTs confirming it safely raises NAD+ levels in humans.

↑ iHerb link is an affiliate link — we may earn a commission at no cost to you.

Origin & tradition

Not traditional: NR is a naturally occurring form of vitamin B3 identified as an NAD+ precursor in 2004.

Why longevity buyers care

Key active: Nicotinamide riboside — direct NAD+ precursor.

NR is phosphorylated by NRK kinases to NMN then to NAD+. Multiple Phase 1/2 RCTs confirm oral NR raises blood NAD+ 40–60% in older adults. Ongoing trials explore muscle, kidney, and metabolic aging.

Effect summary

Studied health outcomes

Editorial summary — This table is curated by hand from published research consensus, not automatically calculated from our trial database. Grades reflect our interpretation of the literature. Treat as a starting point, not a definitive verdict. See the Evidence panel below for the underlying trial and paper counts sourced directly from ClinicalTrials.gov and PubMed.
Health outcomeEffectMagnitudeGrade
NAD+ blood levelsIncreasesStrongA
Mitochondrial function markersIncreasesModerateB
Muscle insulin sensitivityIncreasesMinorC
Blood pressureDecreasesMinorC
Liver fatDecreasesMinorC

Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data

Dosage guidance

How Nicotinamide Riboside (NR) is typically used

Typical dose
250–500 mg/day
Form
capsule (NR as Niagen or equivalent)
Timing
morning, with or without food

NR and NMN have similar effects on NAD+ levels at comparable doses. Some researchers use both together at lower doses. Niacinamide (vitamin B3) achieves similar NAD+ elevation at much lower cost.

Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.

Evidence summary

What the research actually says

79Evidence confidence
Human RCT evidence30 randomized controlled trials · 6 meta-analyses / systematic reviews

Multiple human RCTs on NAD+ elevation; larger aging trials ongoing

NR is phosphorylated by NRK kinases to NMN then to NAD+. Multiple Phase 1/2 RCTs confirm oral NR raises blood NAD+ 40–60% in older adults. Ongoing trials explore muscle, kidney, and metabolic aging.

117registered clinical trials reference this intervention
    3selected from 27+ PubMed papers (longevity / aging angle)
    Key active: Nicotinamide riboside — direct NAD+ precursor.

    According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-06-12. They include trials across many endpoints, not only longevity.

    Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.

    Compare the evidence

    Related ingredients

    Suppliers

    No Nicotinamide Riboside (NR) suppliers listed yet

    Tell us what you need and we will source suppliers for you.

    Request sourcing help